Rosetta Genomics (ROSG +4.8%) gets a lift today after saying earlier that a manuscript on the...

|About: Rosetta Genomics Ltd. (ROSG)|By:, SA News Editor

Rosetta Genomics (ROSG +4.8%) gets a lift today after saying earlier that a manuscript on the development and validation of the Company's microRNA-based diagnostic assay for the classification of renal cell tumors has been accepted for publication by Molecular Oncology.